Woodle M C, Newman M S, Cohen J A
Liposome Technology, Inc., Menlo Park, CA 94025.
J Drug Target. 1994;2(5):397-403. doi: 10.3109/10611869408996815.
Advanced liposomal therapeutics has been attained by liposome surface modification, initially with specific glycolipids and subsequently with surface-grafted PEG, reducing in vivo rapid recognition and uptake, giving prolonged blood circulation, and providing selective localization in tumors and other pathological sites, as described in recent reviews. The result is improved efficacy of encapsulated agents. The surface PEG may produce a steric barrier, as described for colloids. Reduced in vivo uptake may result from inhibition of plasma-protein adsorption, or opsonization, by the steric coating. Several physical studies support this mechanism, including electrophoretic mobility (zeta potential). Our previous results for 2000-dalton PEG indicated a coating thickness about 5 nm, in agreement with independent measurements. We report here results for 750 to 5000-dalton PEGs. The calculated coating thickness increases with molecular weight in a nonlinear fashion. The dependence of blood circulation and tissue distribution on PEG molecular weight correlates with zeta-potential estimates of PEG-coating thickness. Effects on tissue distribution are reported for liver and spleen, the major phagocytic organs. The biological properties of these liposomes depend on the surface polymer rather than the lipid bilayer, yielding important advantages for lipid-mediated control of drug interaction and release without affecting the biodistribution.
先进的脂质体疗法是通过脂质体表面修饰实现的,最初是使用特定的糖脂,随后是表面接枝聚乙二醇(PEG),从而减少体内的快速识别和摄取,实现血液循环时间延长,并在肿瘤和其他病理部位实现选择性定位,如最近的综述所述。其结果是提高了包封药物的疗效。如胶体的情况一样,表面PEG可能会产生空间位阻。体内摄取减少可能是由于空间位阻涂层抑制了血浆蛋白吸附或调理作用。多项物理研究支持这一机制,包括电泳迁移率(ζ电位)。我们之前关于2000道尔顿PEG的结果表明涂层厚度约为5纳米,这与独立测量结果一致。我们在此报告750至5000道尔顿PEG的结果。计算得出的涂层厚度随分子量呈非线性增加。血液循环和组织分布对PEG分子量的依赖性与PEG涂层厚度的ζ电位估计值相关。报告了对主要吞噬器官肝脏和脾脏的组织分布影响。这些脂质体的生物学特性取决于表面聚合物而非脂质双层,这为脂质介导的药物相互作用和释放控制带来了重要优势,而不影响生物分布。